UK

#Clinical trials #Drug discovery #MHRA #UK

UK to introduce clinical trial reforms  

New clinical trial regulations are coming into effect this week (28 April) in the UK, with the changes being the largest package of reforms in over 20 years.   Delivered by the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA), the changes will include faster assessment… Read More

#News

Great British Pounds, Investment
#BioIndustry Association #Europe #Investment #UK

UK leads European biotech investment, BIA reports 

UK biotech led investment in the European market in the first quarter of 2026, new figures from the BioIndustry Association (BIA) show.  The BIA report shows renewed financing was driven by a rebound in venture capital investment and a broader distribution of funding across companies and stages. … Read More

#News

#BioTrinity #Investment #MHRA #Regulatory #UK

Key takes from BioTrinity 2026

DDW Editor Reece Armstrong attended day one of BioTrinity. Here he offers an overview of the conference and the themes to come out of it.   In an era of turbulence, BioTrinity stood out with an air of general positivity concerning the UK’s current standing within the life sciences sector. Though… Read More

#Business & Investment #Exclusive Content

#Life sciences #UK

Construction completed on new UK life science facility 

Construction of a 56,000 sq ft UK life science facility has been completed, Aviva Investors has announced.  Chesterford Research Park, owned by Aviva Investors, now includes ten fully-fitted research and development suites spread over three floors, bringing capacity to approximately 385,000 sq ft of net internal space to UK life science… Read More

#News

Scientist in laboratory
#ABPI #Europe #Rare diseases #UK

UK must become leader in rare disease medicine, report says 

The UK should look to become a European leader in rare disease medicine, a new report says.  The report, ‘Investing in Rarity: The Economic and Personal Value of Improving Treatment for Rare Disease’, shows that if the UK became the best-performing European country on… Read More

#News

#Cancer research #Nuclear medicine #Radiopharmaceuticals #UK

UK project to develop ‘cutting edge’ radiopharmaceuticals 

A £19 million ($25 million) UK programme is set to power the recycling of nuclear materials to develop cutting edge treatments for cancer.  Led by United Kingdom National Nuclear Laboratory (UKNNL) and Medicines Discovery Catapult (MDC), the project will use a radionuclide called lead-212 to create… Read More

#Cancer Research #News

#ABPI #Bispecific Antibodies #Clinical trial #Follicular lymphoma #HIV #National Institute for Health and Care Excellence (NICE) #Novo Nordisk #Nuclear medicine #Prostate cancer #UK #ViiV Healthcare

DDW Highlights: 3 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, more effective treatments were found for both HIV and chronic wounds. Elsewhere, €40,000… Read More

#Podcasts

#ABPI #Bispecific Antibodies #Clinical trial #Follicular lymphoma #GLP-1 #HIV #National Institute for Health and Care Excellence (NICE) #Novo Nordisk #Nuclear medicine #Obesity #Prostate cancer #UK #ViiV Healthcare #Weight loss

This week in Drug Discovery (23 – 27 February) 

News round-up for 23 – 27 February by Bruno Quinney, Content Team at DDW.  This week in drug discovery, more effective treatments have been found for both HIV and chronic wounds. Elsewhere, €40,000 is up for grabs in prostate cancer research.  The top stories:   … Read More

#News

Medical laboratory
#ABPI #Clinical trial #UK

Boost in trial activity would have huge gains, report says 

A new report has highlighted the health and economic opportunity from boosting industry clinical trials.  A report from the European Federation of Pharmaceutical Industries and Associations (EFPIA) highlights increasing clinical trial activity across Europe would have significant health, economic and productivity returns.  According to… Read More

#News

#Clinical trial #Drug discovery #Milner Therapeutics Institute #UK

The role of universities and industry in driving translation of therapeutics

Professor Cathy Tralau-Stewart PhD, Executive Director, Milner Therapeutics Institute, University of Cambridge, UK, asks why a new approach is needed in the UK for getting therapies to the market. Evolution of the translational path   Academic institutions contribute a substantial share of the therapeutic approaches that ultimately reach patients (1), but the path to translating such innovation to… Read More

#Exclusive Content

#Cancer Research Horizons #Genome sequencing #RNA sequencing #UK

Oesophageal cancer dataset made available for commercial use 

Cancer Research Horizons has made one the largest oesophageal cancer datasets available for commercial licensing.  Developed by a team led by Professor Rebecca Fitzgerald at the University of Cambridge, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) dataset represents one of the world’s largest and most comprehensive collections… Read More

#Cancer Research #News

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK

DDW Highlights: 17 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers made a key discovery into cancer survival. Elsewhere, a global research effort… Read More

#Podcasts

#ABPI #Biomanufacturing #Cancer research #Clinical trial #Diabetes #European Union #FDA #Fujifilm #Oncology #Priority Review #Rare diseases #RNA #UK #United States

This week in Drug Discovery (9 – 13 February) 

News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW.  This week in DDW, researchers have made a key discovery into cancer survival. Elsewhere, a global research effort into kidney disease is underway.  The top stories:    Researchers identify RNA linked to cancer… Read More

#News

Researcher pipetting samples in microplate
#ABPI #Clinical trial #Non-animal model (NAM) #UK

UK must develop better pre-clinical models, ABPI warns 

The Association of the British Pharmaceutical Industry (ABPI) has urged scientists to develop better pre-clinical models to accelerate the development of new medicines. The ABPI, in collaboration with the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), has published a landmark review examining the UK's capabilities… Read More

#News #Regulatory

#Blood cancer #Cancer Research UK #UK

Cancer Research UK invests £2.5m in blood cancer care 

Cancer Research UK has allocated £2.5 million ($3.4 million) to researchers at the University of York to help transform care for patients diagnosed with blood cancers.  The funding is for the world leading Haematological Malignancy Research Network (HMRN), one of the most comprehensive blood cancer research networks in the… Read More

#Cancer Research #News

#Alzheimer's #Bacteria #Brain cancer #Cancer immunotherapy #Clinical trial #Drug resistance #Fast Track designation #FDA #Gene therapy #Life sciences #Melanoma #Siren Biotechnology #UK #UK government #University of Sydney

This week in Drug Discovery (2 – 6 February) 

News round-up for 2 – 6 February by Bruno Quinney, Content Team at DDW.  This week in DDW, innovative therapies could pave the way to more effective cancer treatments. Elsewhere, how can brain function be improved in Alzheimer’s patients?  The top stories:      Immunotherapy before surgery… Read More

#News